Taysha Gene Therapies Inc
For the period ended May 29, 2024. Filed Apr 18, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 29, 2024 · Filed Apr 18, 2024
Use the contents to explore the available documents and sections.
Contents
Code of Ethics
The Company has adopted the Taysha**** Code of Business Conduct and Ethics that applies to all officers, directors and employees. The Code of Business Conduct and Ethics is available on our website atwww.tayshagtx.com. If the Company makes any substantive amendments to the Code of Business Conduct and Ethics or grants any waiver from a provision of the Code to any executive officer or director, the Company will promptly disclose the nature of the amendment or waiver on its website.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.